Subject
Editions published in Stem Cells 5291
-
Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony stimulating factor).
-
In vitro enhancement of erythropoiesis by steel factor in diamond-blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor
-
Megakaryocytopoiesis and platelet production: Does stem cell factor play a role?
-
Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s).
-
The biology of interleukin 11.
-
Time lapse video recordings of highly purified human hematopoietic progenitor cells in culture
-
CD34 antigen: molecular features and potential clinical applications.
-
The role of stem cell factor in mobilization of peripheral blood progenitor cells: synergy with G-CSF.
-
Oligodeoxynucleotide-based therapeutics for human leukemias
-
Structure-function analyses of the kit receptor for the steel factor
-
In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia
-
Molecular genetic approaches to the elucidation of hematopoietic stem cell function
-
Stem cell factor enhances in vivo effects of granulocyte colony stimulating factor for stimulating mobilization of peripheral blood progenitor cells
-
Cytokine enhancement of peripheral blood stem cells
-
The in vitro and in vivo effects of stem cell factor on human hematopoiesis
-
Erythropoiesis in diamond-blackfan anemia and the role of interleukin 3 and steel factor
-
Chronic myelogenous leukemia: in search of the benign hematopoietic stem cell
-
Biological strategies for the selective manipulation of normal and leukemic stem cells
-
Hemopoietic stem cells: technical and methodological considerations
-
Erythroid regulatory elements
-
Peripheral blood stem cell transplantations: past, present and future
-
IL-3 and peripheral blood stem cell harvesting
-
Is our current strategy in manipulating hemopoiesis in autologous transplantation correct?
-
Is blood or bone marrow better?
-
Interleukin 3 and interleukin 3/GM-CSF combination therapy--clinical implications
-
Interleukin 11: an overview
-
Aging and lymphokine production by T cell subsets
-
Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma
-
Stringently purified human hematopoietic progenitors/stem cells: analysis of cellular/molecular mechanisms underlying early hematopoiesis
-
Is there a place for autologous bone marrow transplantation in chronic myeloid leukemia?
-
Residual Ph-negative stem cells in chronic myeloid leukemia--sometimes or always?
-
Therapy of chronic myelogenous leukemia
Subject -